In the journey to outperform the market, investors delve into the art of stock selection. Choosing the right stocks can be a powerful driver for wealth accumulation.
After finishing at $6.50 in the prior trading day, Fennec Pharmaceuticals Inc (NASDAQ: FENC) closed at $6.13, down -5.69%. In other words, the price has decreased by -$5.69 from its previous closing price. On the day, 0.6 million shares were traded. FENC stock price reached its highest trading level at $6.545 during the session, while it also had its lowest trading level at $6.1.
Ratios:
Our goal is to gain a better understanding of FENC by taking a closer look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 6.31 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 7.10. For the most recent quarter (mrq), Quick Ratio is recorded 6.56 and its Current Ratio is at 6.72.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Cantor Fitzgerald on November 22, 2022, Upgraded its rating to Overweight and sets its target price to $12 from $9 previously.
On September 07, 2022, CapitalOne started tracking the stock assigning a Overweight rating and target price of $11.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Mar 05 ’25 when Raykov Rosty sold 10,000 shares for $6.79 per share. The transaction valued at 67,900 led to the insider holds 68,725 shares of the business.
ROSTISLAV RAYKOV bought 10,000 shares of FENC for $67,930 on Mar 05 ’25. On Feb 14 ’25, another insider, RALLIS CHRIS A, who serves as the Director of the company, sold 1,186 shares for $6.82 each. As a result, the insider received 8,089 and left with 53,020 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, FENC now has a Market Capitalization of 173290816 and an Enterprise Value of 160251968. For the stock, the TTM Price-to-Sale (P/S) ratio is 3.54. Its current Enterprise Value per Revenue stands at 3.371 whereas that against EBITDA is 44.514.
Stock Price History:
The Beta on a monthly basis for FENC is 0.29, which has changed by -0.38329983 over the last 52 weeks, in comparison to a change of 0.07903516 over the same period for the S&P500. Over the past 52 weeks, FENC has reached a high of $11.49, while it has fallen to a 52-week low of $3.96. The 50-Day Moving Average of the stock is -4.19%, while the 200-Day Moving Average is calculated to be 5.15%.
Shares Statistics:
The stock has traded on average 64.58K shares per day over the past 3-months and 130140 shares per day over the last 10 days, according to various share statistics. A total of 27.29M shares are outstanding, with a floating share count of 22.91M. Insiders hold about 16.46% of the company’s shares, while institutions hold 58.92% stake in the company. Shares short for FENC as of 1740700800 were 1925077 with a Short Ratio of 29.81, compared to 1738281600 on 1953811. Therefore, it implies a Short% of Shares Outstanding of 1925077 and a Short% of Float of 10.24.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
